Literature DB >> 10065663

Decline in FEV1 related to smoking status in individuals with severe alpha1-antitrypsin deficiency (PiZZ).

E Piitulainen1, S Eriksson.   

Abstract

Severe alpha1-antitrypsin (AAT) deficiency predisposes to emphysema development. Highly variable rates of decline in lung function are reported in PiZZ individuals. The annual decline in forced expiratory volume in one second (FEV1; delta FEV1) was analysed in relation to smoking status in a cohort of 608 adult PiZZ individuals included in the Swedish national AAT deficiency register. Delta FEV1 was analysed in 211 never-smokers, in 351 exsmokers, and in 46 current smokers after performing at least two spirometries during a follow-up time of 1 yr or longer (median 5.5 yrs, range 1-31). The adjusted mean delta FEV1 in never-smokers was 47 mL x yr(-1) (95% confidence interval (CI) 41-53 mL x yr(-1)), 41 mL x yr(-1) (95% CI 36-48 mL x yr(-1)) in exsmokers, and 70 mL x yr(-1) (95% CI 58-82 mL x yr(-1)) in current smokers. A dose-response relationship was found between cigarette consumption and delta FEV1 in current smokers and exsmokers. In never-smokers, a greater delta FEV1 was found after 50 yrs of age than before. No sex differences were found in delta FEV1. In conclusion, among PiZZ individuals, the change in forced expiratory volume in one second is essentially the same in never-smokers and exsmokers. Smoking is associated with a dose-dependent increase in the change in forced expiratory volume in one second.

Entities:  

Mesh:

Year:  1999        PMID: 10065663     DOI: 10.1183/09031936.99.13224799

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  28 in total

1.  Secreted modular calcium-binding protein 2 haplotypes are associated with pulmonary function.

Authors:  Jemma B Wilk; Alan Herbert; Christina M Shoemaker; Daniel J Gottlieb; Samer Karamohamed
Journal:  Am J Respir Crit Care Med       Date:  2007-01-04       Impact factor: 21.405

2.  Rapid and inexpensive detection of alpha1-antitrypsin deficiency-related alleles S and Z by a real-time polymerase chain reaction suitable for a large-scale population-based screening.

Authors:  Marcin P Kaczor; Marek Sanak; Andrew Szczeklik
Journal:  J Mol Diagn       Date:  2007-02       Impact factor: 5.568

3.  Validation of computed tomographic lung densitometry for monitoring emphysema in alpha1-antitrypsin deficiency.

Authors:  D G Parr; B C Stoel; J Stolk; R A Stockley
Journal:  Thorax       Date:  2006-03-14       Impact factor: 9.139

Review 4.  Chronic obstructive pulmonary disease. 1: Susceptibility factors for COPD the genotype-environment interaction.

Authors:  A J Sandford; E K Silverman
Journal:  Thorax       Date:  2002-08       Impact factor: 9.139

Review 5.  Alpha 1-antitrypsin deficiency. 3: Clinical manifestations and natural history.

Authors:  M Needham; R A Stockley
Journal:  Thorax       Date:  2004-05       Impact factor: 9.139

6.  Sputum chemotactic activity in chronic obstructive pulmonary disease: effect of alpha(1)-antitrypsin deficiency and the role of leukotriene B(4) and interleukin 8.

Authors:  I S Woolhouse; D L Bayley; R A Stockley
Journal:  Thorax       Date:  2002-08       Impact factor: 9.139

7.  Tailored pharmacokinetic dosing allows self-administration and reduces the cost of IV augmentation therapy with human alpha(1)-antitrypsin.

Authors:  Eeva Piitulainen; Elisabeth Bernspång; Sven Björkman; Erik Berntorp
Journal:  Eur J Clin Pharmacol       Date:  2003-05-01       Impact factor: 2.953

Review 8.  Alpha1-antitrypsin deficiency. 4: Molecular pathophysiology.

Authors:  D A Lomas; H Parfrey
Journal:  Thorax       Date:  2004-06       Impact factor: 9.139

Review 9.  Cigarette smoke and CFTR: implications in the pathogenesis of COPD.

Authors:  Andras Rab; Steven M Rowe; S Vamsee Raju; Zsuzsa Bebok; Sadis Matalon; James F Collawn
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-08-09       Impact factor: 5.464

10.  Alpha-1-antitrypsin augmentation therapy in deficient individuals enrolled in the Alpha-1 Foundation DNA and Tissue Bank.

Authors:  Adriano R Tonelli; Farshid Rouhani; Ning Li; Pam Schreck; Mark L Brantly
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.